FAM111B and central nervous system cancer: To assess the prognostic significance of FAM111B in glioma patients and its association with clinical characteristics, we conducted Kaplan–Meier survival analyses for overall survival (OS) and disease-free survival (DFS) using patient data from the TCGA database.